IART – Integra LifeSciences Holdings Corporation
IART — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
9.32
Margin Of Safety %
18
Put/Call OI Ratio
0.33
EPS Next Q Diff
0.24
EPS Last/This Y
9.2
EPS This/Next Y
0.15
Price
17.25
Target Price
19.56
Analyst Recom
2.75
Performance Q
Upside
-111.5%
Beta
1.21
Ticker: IART
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | IART | 18.59 | 0.26 | 0.00 | 770 |
| 2026-07-14 | IART | 18.4 | 0.26 | 0.00 | 770 |
| 2026-07-15 | IART | 18.77 | 0.26 | 0.00 | 770 |
| 2026-07-16 | IART | 19.87 | 0.26 | 0.33 | 770 |
| 2026-07-17 | IART | 19.25 | 0.27 | 0.20 | 765 |
| 2026-07-20 | IART | 18.89 | 0.26 | 2.70 | 681 |
| 2026-07-21 | IART | 19 | 0.30 | 0.00 | 731 |
| 2026-07-22 | IART | 18.83 | 0.29 | 0.97 | 747 |
| 2026-07-23 | IART | 18.57 | 0.31 | 0.11 | 809 |
| 2026-07-24 | IART | 19.79 | 0.30 | 3.45 | 829 |
| 2026-07-27 | IART | 19.51 | 0.29 | 20.00 | 851 |
| 2026-07-28 | IART | 19.74 | 0.35 | 3.86 | 897 |
| 2026-07-29 | IART | 16.23 | 0.36 | 0.54 | 900 |
| 2026-07-30 | IART | 17.1 | 0.33 | 2.18 | 1094 |
| 2026-07-31 | IART | 16.63 | 0.33 | 17.29 | 1084 |
| 2026-08-03 | IART | 17.88 | 0.33 | 0.88 | 1089 |
| 2026-08-04 | IART | 17.9 | 0.33 | 0.00 | 1104 |
| 2026-08-05 | IART | 17.68 | 0.33 | 0.09 | 1105 |
| 2026-08-06 | IART | 17.1 | 0.33 | 7.33 | 1109 |
| 2026-08-07 | IART | 17.25 | 0.33 | 5.50 | 1109 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | IART | 18.57 | 7.6 | - | 2.45 |
| 2026-07-14 | IART | 18.41 | 7.6 | - | 2.45 |
| 2026-07-15 | IART | 18.77 | 7.6 | - | 2.45 |
| 2026-07-16 | IART | 19.87 | 7.6 | - | 2.45 |
| 2026-07-17 | IART | 19.26 | 7.5 | - | 2.45 |
| 2026-07-20 | IART | 18.89 | 7.5 | - | 2.45 |
| 2026-07-21 | IART | 19.00 | 7.5 | - | 2.45 |
| 2026-07-22 | IART | 18.83 | 7.5 | - | 2.45 |
| 2026-07-23 | IART | 18.57 | 7.5 | - | 2.45 |
| 2026-07-24 | IART | 19.79 | 7.5 | - | 2.45 |
| 2026-07-27 | IART | 19.52 | 7.5 | - | 2.45 |
| 2026-07-28 | IART | 19.75 | 7.5 | - | 2.45 |
| 2026-07-29 | IART | 16.48 | 7.5 | - | 2.45 |
| 2026-07-30 | IART | 17.11 | 7.5 | - | 2.45 |
| 2026-07-31 | IART | 16.64 | 6.8 | - | 2.45 |
| 2026-08-03 | IART | 17.89 | 6.8 | - | 2.45 |
| 2026-08-04 | IART | 17.89 | 6.8 | - | 2.45 |
| 2026-08-05 | IART | 17.68 | 6.8 | - | 2.46 |
| 2026-08-06 | IART | 17.08 | 6.8 | - | 2.46 |
| 2026-08-07 | IART | 17.25 | 4.3 | - | 2.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | IART | 0.00 | 0.30 | 9.61 |
| 2026-07-14 | IART | 0.00 | 0.30 | 9.61 |
| 2026-07-15 | IART | 0.00 | 0.30 | 9.61 |
| 2026-07-16 | IART | 0.00 | 0.30 | 9.61 |
| 2026-07-17 | IART | 0.00 | 0.30 | 9.61 |
| 2026-07-20 | IART | 0.00 | 0.28 | 9.61 |
| 2026-07-21 | IART | 0.00 | 0.28 | 9.61 |
| 2026-07-22 | IART | 0.00 | 0.28 | 9.61 |
| 2026-07-23 | IART | 0.00 | 0.28 | 9.61 |
| 2026-07-24 | IART | 0.00 | 0.28 | 9.61 |
| 2026-07-27 | IART | 0.00 | 0.24 | 9.32 |
| 2026-07-28 | IART | 0.00 | 0.24 | 9.32 |
| 2026-07-29 | IART | 0.00 | 0.24 | 9.32 |
| 2026-07-30 | IART | 0.00 | 0.24 | 9.32 |
| 2026-07-31 | IART | 0.00 | 0.24 | 9.32 |
| 2026-08-03 | IART | 0.00 | -0.02 | 9.32 |
| 2026-08-04 | IART | 0.00 | -0.02 | 9.32 |
| 2026-08-06 | IART | 0.00 | -0.02 | 9.32 |
| 2026-08-07 | IART | 0.00 | -0.02 | 9.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.56
Avg. EPS Est. Current Quarter
0.56
Avg. EPS Est. Next Quarter
0.8
Insider Transactions
Institutional Transactions
-0.02
Beta
1.21
Average Sales Estimate Current Quarter
416
Average Sales Estimate Next Quarter
447
Fair Value
20.36
Quality Score
53
Growth Score
45
Sentiment Score
56
Actual DrawDown %
77.5
Max Drawdown 5-Year %
-88.3
Target Price
19.56
P/E
Forward P/E
6.62
PEG
0.78
P/S
0.81
P/B
1.29
P/Free Cash Flow
52
EPS
-0.09
Average EPS Est. Cur. Y
2.46
EPS Next Y. (Est.)
2.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-0.44
Relative Volume
0.63
Return on Equity vs Sector %
-28
Return on Equity vs Industry %
-12.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
◆
IART
Healthcare
$17.25
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
14/20
Pullback
19/25
Volume
6/15
Valuation
13/20
TP/AR
2/10
Options
7/10
RSI
45.4
Range 1M
26.4%
Sup Dist
2.3%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
9/25
Growth
8/30
Estimates
4/20
Inst/Vol
0/15
Options
5/10
EPS Yr
10.2%
52W%
72.2%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+124.5% upside
Quality
6/30
Valuation
24/30
Growth
10/25
Stability
5/10
LT Trend
0/5
Upside
+124.5%
Quality
53
MoS
18%
Click a card to see score breakdown
Full Analysis →
IART — P/E HistoricalMedical Devices
Sector: Healthcare
Industry: Medical Devices
Employees: 4427
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
IART
Latest News
—
Caricamento notizie per IART…
stock quote shares IART – Integra LifeSciences Holdings Corporation Stock Price stock today
news today IART – Integra LifeSciences Holdings Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch IART – Integra LifeSciences Holdings Corporation yahoo finance google finance
stock history IART – Integra LifeSciences Holdings Corporation invest stock market
stock prices IART premarket after hours
ticker IART fair value insiders trading